Sequential functional imaging with technetium-99m hexakis-2-methoxyisobutylisonitrile and indium-111 octreotide: can we predict the response to chemotherapy in small cell lung cancer?

Eur J Nucl Med. 1995 Feb;22(2):177-80. doi: 10.1007/BF00838949.

Abstract

A case of small cell lung carcinoma (SCLC) demonstrating uptake on functional indium-111 octreotide scintigraphy is presented. Technetium-99m hexakis-2-methoxyisobutylisonitrile (MIBI) scintigraphy clearly delineated an absence of radionuclide uptake at the tumour site. This suggested the presence of multidrug resistance-mediated P glycoprotein (Pgp) on tumour cells, which recognizes certain chemotherapeutic agents as well as MIBI as a substrate and avoids radionuclide concentration. Following three courses of chemotherapy, the patient failed to improve and eventually died. This case demonstrates the importance of functional images, which have the potential to predict the outcome in response to chemotherapy.

Publication types

  • Case Reports

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / analysis*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Small Cell / diagnostic imaging*
  • Carcinoma, Small Cell / drug therapy*
  • Drug Resistance, Multiple*
  • Humans
  • Indium Radioisotopes*
  • Lung / diagnostic imaging*
  • Lung Neoplasms / diagnostic imaging*
  • Lung Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Octreotide*
  • Prognosis
  • Radionuclide Imaging
  • Technetium Tc 99m Sestamibi*
  • Treatment Failure

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Indium Radioisotopes
  • Technetium Tc 99m Sestamibi
  • Octreotide